EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Laetiporus sulphureus polysaccharides mitigate colitis by reshaping the gut microbiota and regulating immune responses

Sharafat Ali, Yamina Alioui, Imran Khan, Hidayat Ullah, Mujeeb Ur Rahman, Aamna Atta, Mohammed Abusidu, Muhammad Ilyas, Uzma Noor, Renzhen Ma, Muhsin Ali, Nabeel Ahmed Farooqui und 5 weitere

Frontiers in Pharmacology · 15.04.2026 · 17

DOI: 10.3389/fphar.2026.1705032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.04.2026. Verfasst von Sharafat Ali und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Dalian Medical University, Dalian, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel disease (IBD) involves epithelial barrier disruption, immune dysregulation, and microbial imbalance. The present study investigated the protective mechanisms of Laetiporus sulphureus polysaccharides (LSP) in dextran sulfate sodium (DSS)-induced colitis, focusing on intestinal barrier restoration, immunomodulation, and gut microbiota remodeling.

Methods

LSP was structurally characterized using HPLC, FTIR, and SEM analyses, revealing a heteropolysaccharide primarily composed of glucose (55.16%), galactose (16.55%), and mannose (13.52%). Experimental colitis was induced in BALB/c mice with 3% DSS, followed by oral LSP administration (200 or 400 mg/kg). Disease severity, histopathology, barrier markers, cytokine profiles, macrophage polarization, and gut microbiota composition were evaluated using biochemical assays, immunofluorescence, IHC, and 16S rRNA sequencing.

Results

LSP significantly mitigated DSS-induced colitis by reducing the disease activity index by approximately 60% (∼2.5-fold, p < 0.001) and restoring colon length (∼1.5-fold, p < 0.01). Barrier integrity improved via enhanced mucin-2 expression (∼3.5-fold) and tight junction proteins Occludin, Claudin-1, and ZO-1 (∼5–9-fold). LSP suppressed pro-inflammatory cytokines TNF-α, IL-6, and IL-1β (∼2–3-fold) while upregulating anti-inflammatory mediators IL-10 and TGF-β (∼2.5–3-fold), reflecting a rebalanced mucosal immune milieu. 16S rRNA sequencing demonstrated reversal of DSS-induced dysbiosis, characterized by a reduction in pathogenic Escherichia–Shigella (∼3.8-fold) and Enterobacteriaceae (∼3.5-fold), and enrichment of beneficial taxa including Lactobacillus , Bifidobacterium, and Ruminococcus (∼2–4-fold).

Conclusion

LSP exerts multi-targeted protection against colitis by reinforcing epithelial barrier function, attenuating inflammation, and reshaping gut microbial ecology. These findings highlight LSP as a promising natural therapeutic candidate for IBD. Further metabolomic and meta transcriptomic analyses are warranted to elucidate the microbial metabolites and molecular pathways mediating these protective effects.

Schlagwörter

Stichwörter der Autor:innen

Laetiporus sulphureus polysaccharidesepithelial barriergut microbiotaimmune modulationulcerative colitis

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Dalian Medical University, Dalian, China.
  • Department of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian, China.
  • Department of Microecology, College of Basic Medical Science, Dalian Medical University, Dalian, China.
  • Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, and School of Pharmacy, Guangdong Medical University, Dongguan, China.
  • Department of Physiology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.

Zitieren

APA

Ali, S., Alioui, Y., Khan, I., Ullah, H., Rahman, M. U., Atta, A., Abusidu, M., Ilyas, M., Noor, U., Ma, R., Ali, M., Farooqui, N. A., Deng, T., Wang, G., Xin, Y., Sha, S., & Ma, Y. (2026). Laetiporus sulphureus polysaccharides mitigate colitis by reshaping the gut microbiota and regulating immune responses. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1705032

Vancouver

Ali S, Alioui Y, Khan I, Ullah H, Rahman MU, Atta A, et al. Laetiporus sulphureus polysaccharides mitigate colitis by reshaping the gut microbiota and regulating immune responses. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1705032

BibTeX
@article{Ali2026,
  author = {Ali, Sharafat and Alioui, Yamina and Khan, Imran and Ullah, Hidayat and Rahman, Mujeeb Ur and Atta, Aamna and Abusidu, Mohammed and Ilyas, Muhammad and Noor, Uzma and Ma, Renzhen and Ali, Muhsin and Farooqui, Nabeel Ahmed and Deng, Ting and Wang, Guangyang and Xin, Yi and Sha, Shanshan and Ma, Yufang},
  title = {Laetiporus sulphureus polysaccharides mitigate colitis by reshaping the gut microbiota and regulating immune responses},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1705032}
}
Kostenlos starten →